JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, J.-H.
Right arrow Articles by Harding, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, J.-H.
Right arrow Articles by Harding, J. W.

Vol. 289, Issue 2, 1075-1083, May 1999

Structural Analysis of Angiotensin IV Receptor (AT4) from Selected Bovine Tissues

Jian-Hua Zhang, Jodie M. Hanesworth, Michael F. Sardinia, Jeremiah A. Alt, John W. Wright and Joseph W. Harding

Department of Veterinary and Comparative Anatomy, Physiology and Pharmacology, Washington State University, Pullman, Washington

The angiotensin IV receptor (AT4) receptor is widely distributed in both species and tissues. This broad distribution appears to be reflected in an equally diverse repertoire of physiological actions that are mediated through AT4 receptors. This breadth of location and function of AT4 receptors encourages speculation that multiple AT4 isoforms might exist. In this study, we compared the structural properties of bovine AT4 receptors from adrenals, kidney, heart, thymus, bladder, aorta, and hippocampus. These comparisons were made using polyacrylamide gel electrophoresis or HPLC analysis of AT4 receptors that had been covalently radiolabeled with the AT4-specific photoprobe 125I-benzoyl phenylalamine-angiotensin IV. Except for the hippocampal AT4 receptor, the binding subunit in all tissues had a molecular mass of approximately 165 kDa and associated with additional subunits via disulfide linkages. The hippocampal receptor was significantly smaller (150 kDa) and did not appear to possess other disulfide-linked subunits. The receptor was highly glycosylated in all tissues examined. Peptide mapping following cleavage of 125I-labeled receptor with endopeptidase C or cyanogen bromide resulted in complex cleavage patterns. Together these mapping studies demonstrated the uniqueness of the hippocampal receptor and further suggested that other AT4 isoforms may exist and be variably distributed among bovine tissues. In agreement with the peptide mapping studies, differences in the binding pattern of several AngIV analogs were observed among the various tissues.

0022-3565/99/2892-1075$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Journal of Renin-Angiotensin-Aldosterone SystemHome page
P. R Gard, P. Daw, Z. Sayyad Mashhour, and P. Tran
Interactions of angiotensin IV and oxytocin on behaviour in mice
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2007; 8(3): 133 - 138.
[Abstract] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. Lee, T. Mustafa, S. G. McDowall, F. A. O. Mendelsohn, M. Brennan, R. A. Lew, A. L. Albiston, and S. Y. Chai
Structure-Activity Study of LVV-Hemorphin-7: Angiotensin AT4 Receptor Ligand and Inhibitor of Insulin-Regulated Aminopeptidase
J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 205 - 211.
[Abstract] [Full Text]

Home page
 Journal of Renin-Angiotensin-Aldosterone SystemHome page
G. Vauquelin, Y. Michotte, I. Smolders, S. Sarre, G. Ebinger, A. Dupont, and P. Vanderheyden
Cellular targets for angiotensin II fragments: pharmacological and molecular evidence
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2002; 3(4): 195 - 204.
[Abstract] [PDF]

Home page
 Journal of Renin-Angiotensin-Aldosterone SystemHome page
T. Mustafa, Joo Hyung Lee, Siew Yeen Chai, A. L Albiston, S. G McDowall, and F. A. Mendelsohn
Bioactive angiotensin peptides: focus on angiotensin IV
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2001; 2(4): 205 - 210.
[PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. K. HANDA
Characterization and Signaling of the AT4 Receptor in Human Proximal Tubule Epithelial (HK-2) Cells
J. Am. Soc. Nephrol., March 1, 2001; 12(3): 440 - 449.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. Ito and A. F. Sved
Pharmacological profile of depressor response elicited by sarthran in rat ventrolateral medulla
Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2961 - H2966.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. K. Handa, J. W. Harding, and S. M. Simasko
Characterization and Function of the Bovine Kidney Epithelial Angiotensin Receptor Subtype 4 Using Angiotensin IV and Divalinal Angiotensin IV as Receptor Ligands
J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1242 - 1249.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.